ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,045,393 | +103202.7% | 35,229 | -25.5% | 0.01% | -26.7% |
| Q4 2022 | $1,980 | -99.9% | 47,309 | -1.3% | 0.02% | 0.0% |
| Q3 2022 | $1,770,000 | +400.0% | 47,952 | +328.7% | 0.02% | +400.0% |
| Q2 2022 | $354,000 | -3.5% | 11,185 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $367,000 | +4.0% | 11,195 | +31.1% | 0.00% | 0.0% |
| Q4 2021 | $353,000 | +14.6% | 8,540 | +2.1% | 0.00% | +50.0% |
| Q3 2021 | $308,000 | +32.8% | 8,362 | -4.5% | 0.00% | +100.0% |
| Q2 2021 | $232,000 | -24.4% | 8,756 | -5.9% | 0.00% | -50.0% |
| Q1 2021 | $307,000 | -1.3% | 9,303 | -4.0% | 0.00% | 0.0% |
| Q4 2020 | $311,000 | +11.5% | 9,693 | +0.7% | 0.00% | 0.0% |
| Q3 2020 | $279,000 | 0.0% | 9,627 | -0.6% | 0.00% | 0.0% |
| Q2 2020 | $279,000 | -25.6% | 9,685 | +7.8% | 0.00% | -33.3% |
| Q1 2020 | $375,000 | -29.9% | 8,987 | +2.8% | 0.00% | -25.0% |
| Q4 2019 | $535,000 | -21.0% | 8,741 | +0.3% | 0.00% | -20.0% |
| Q3 2019 | $677,000 | +5.6% | 8,718 | +10.0% | 0.01% | 0.0% |
| Q2 2019 | $641,000 | +12.5% | 7,928 | -3.8% | 0.01% | 0.0% |
| Q1 2019 | $570,000 | +35.4% | 8,239 | +3.1% | 0.01% | +25.0% |
| Q4 2018 | $421,000 | -6.2% | 7,991 | -0.9% | 0.00% | 0.0% |
| Q3 2018 | $449,000 | -33.3% | 8,065 | -16.1% | 0.00% | -20.0% |
| Q2 2018 | $673,000 | +19.1% | 9,612 | +3.1% | 0.01% | +25.0% |
| Q1 2018 | $565,000 | -11.2% | 9,320 | +1.7% | 0.00% | 0.0% |
| Q4 2017 | $636,000 | +15.4% | 9,167 | -2.6% | 0.00% | 0.0% |
| Q3 2017 | $551,000 | +36.0% | 9,407 | +13.3% | 0.00% | +33.3% |
| Q2 2017 | $405,000 | -16.7% | 8,305 | -6.2% | 0.00% | -25.0% |
| Q1 2017 | $486,000 | -4.3% | 8,855 | +3.8% | 0.00% | 0.0% |
| Q4 2016 | $508,000 | -8.1% | 8,532 | +5.6% | 0.00% | -20.0% |
| Q3 2016 | $553,000 | +3.4% | 8,081 | +5.6% | 0.01% | 0.0% |
| Q2 2016 | $535,000 | +58.3% | 7,651 | -2.2% | 0.01% | +66.7% |
| Q1 2016 | $338,000 | +11.2% | 7,823 | +0.4% | 0.00% | 0.0% |
| Q4 2015 | $304,000 | +0.7% | 7,791 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $302,000 | -70.6% | 7,642 | -53.8% | 0.00% | -25.0% |
| Q2 2015 | $1,026,000 | +104.0% | 16,530 | +105.8% | 0.00% | 0.0% |
| Q1 2015 | $503,000 | – | 8,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 328,494 | $15,137,000 | 4.72% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $13,824,000 | 2.78% |
| Mesirow Financial Investment Management, Inc. | 12,277 | $566,000 | 1.63% |
| Parkman Healthcare Partners LLC | 137,226 | $6,323,000 | 1.40% |
| Global Alpha Capital Management Ltd. | 284,831 | $13,125,000 | 1.27% |
| Stonepine Capital Management, LLC | 52,290 | $2,410,000 | 1.11% |
| 1492 Capital Management LLC | 43,611 | $2,010,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,770 | $3,445,000 | 0.81% |
| Walthausen & Co., LLC | 61,456 | $2,832,000 | 0.74% |
| Rubric Capital Management LP | 307,557 | $14,172,000 | 0.67% |